Next Article in Journal
Investigating the Effect and Potential Mechanism of Rhamnetin 3-O-α-Rhamnoside on Acute Liver Injury In Vivo and In Vitro
Previous Article in Journal
Post-Marketing Pharmacovigilance of Canakinumab from the FDA Adverse Event Reporting System (FAERS)
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(1), 115; https://doi.org/10.3390/ph18010115
Action Date Notes Link
article pdf uploaded. 16 January 2025 15:33 CET Version of Record https://www.mdpi.com/1424-8247/18/1/115/pdf-vor
article xml file uploaded 17 January 2025 08:54 CET Original file -
article xml uploaded. 17 January 2025 08:54 CET Update https://www.mdpi.com/1424-8247/18/1/115/xml
article pdf uploaded. 17 January 2025 08:54 CET Updated version of record https://www.mdpi.com/1424-8247/18/1/115/pdf
article html file updated 17 January 2025 08:55 CET Original file https://www.mdpi.com/1424-8247/18/1/115/html
Back to TopTop